Your session is about to expire
← Back to Search
Behavioral Intervention
SURGE Support Program for Cancer Trial Enrollment
N/A
Recruiting
Led By Nadine J McCleary, MD MPH
Research Sponsored by Nadine McCleary, MD, MPH
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Gastrointestinal, hematologic, or thoracic cancer
Adult (age 18 years or older)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 90 days of enrollment
Awards & highlights
Study Summary
This trial will help researchers learn more about how best to support patients in their decision to undergo genomic testing as part of a clinical trial.
Who is the study for?
The SURGE trial is for adults over 18 with advanced gastrointestinal, blood, or lung cancer. It's focused on helping underrepresented groups like Black, Latinx, American Indian, Pacific Islander individuals, those with limited English proficiency in Spanish, older adults (70+), and people from low-income areas or facing social challenges.Check my eligibility
What is being tested?
SURGE tests a support system to help these patients join genomic-based cancer trials. The intervention includes a personal guide (navigator), text message surveys, and an educational video to overcome barriers to precision therapy access.See study design
What are the potential side effects?
Since SURGE is not testing a drug but an intervention program aimed at improving trial enrollment processes through education and navigation services, there are no direct medical side effects associated with typical clinical interventions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My cancer is in the stomach, blood, or chest area.
Select...
I am 18 years old or older.
Select...
I have an advanced cancer that needs treatment.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 90 days of enrollment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 90 days of enrollment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Genomic testing uptake
Secondary outcome measures
Acceptability of questionnaire modality
Patient interaction with the intervention
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Arm C (informational video and patient navigation)Experimental Treatment1 Intervention
Participants will complete screening questionnaire via text or by phone to establish baseline awareness and interest in clinical trials and then randomized to the SURGE intervention where they will receive:
Informational Video and Patient Navigation
Group II: Arm B (informational video)Experimental Treatment1 Intervention
Participants will complete screening questionnaire via text or by phone to establish baseline awareness and interest in clinical trials and then randomized to the SURGE intervention where they will receive:
Informational Video
Group III: Arm A (standard of care)Active Control1 Intervention
Participants will complete screening questionnaire via text or by phone to establish baseline awareness and interest in clinical trials and then randomized to Standard of Care (SOC) and receive:
Standard of Care
Find a Location
Who is running the clinical trial?
Nadine McCleary, MD, MPHLead Sponsor
Bristol-Myers SquibbIndustry Sponsor
2,650 Previous Clinical Trials
4,130,622 Total Patients Enrolled
Nadine McCleary MD, MPHLead Sponsor
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My cancer is in the stomach, blood, or chest area.I am unable to give my consent for participation.My cancer only needs regular monitoring.I am 18 years old or older.I speak a language that is not English or Spanish.I have an advanced cancer that needs treatment.I am Black, Latinx, or over 70 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Arm B (informational video)
- Group 2: Arm A (standard of care)
- Group 3: Arm C (informational video and patient navigation)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger